Dr Reddy’s launches Esomeprazole capsules
23 July 2018 | News
Esomeprazole Magnesium Delayed-Release Capsules is an OTC proton pump inhibitor used to treat frequent heartburn occurring two or more days in a week in adults.
Image credit- mirror.co.uk
Dr Reddy’s Laboratories Ltd has launched Esomeprazole Magnesium Delayed-Release Capsules in the US market. This is an over-the-counter (OTC) therapeutic equivalent generic version of Nexium capsules.
Esomeprazole Magnesium Delayed-Release Capsules is an OTC proton pump inhibitor used to treat frequent heartburn occurring two or more days in a week in adults.
"This launch continues to demonstrate our R&D and manufacturing capabilities to bring newer store-brand OTC medications to the market,” said Milan Kalawadia, Vice President and Head, US OTC and Speciality Rx businesses, Dr. Reddy’s Laboratories.
The combined market of Nexium capsules and private label OTC Esomeprazole Magnesium products had US sales of approximately $311 million for the most recent 12 months ended May 2018.
